4 Analysts Have This To Say About Omega Therapeutics
4 Analysts Have This To Say About Omega Therapeutics
4位分析师对欧米茄疗法有这样的看法
Ratings for Omega Therapeutics (NASDAQ:OMGA) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，有4位分析师提供了欧米茄疗法（纳斯达克股票代码：OMGA）的评级，显示了看涨和看跌的观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表简要概述了分析师最近的评级，提供了对过去30天情绪变化的见解，并与前几个月进行了比较以获得整体视角。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $8.75, a high estimate of $12.00, and a low estimate of $7.00. A 9.51% drop is evident in the current average compared to the previous average price target of $9.67.
分析师12个月目标股价的见解已经公布，平均目标股价为8.75美元，最高估计为12.00美元，低估值为7.00美元。与之前的平均目标股价9.67美元相比，当前的平均价格下降了9.51％。
Analyzing Analyst Ratings: A Detailed Breakdown...
分析分析师评...
登录免费看全文
登录/注册